1
Jean Pierre Sommadossi, Gilles Gosselin, Claire Pierra, Christian Perigaud, Suzanne Peyrottes: Compounds and pharmaceutical compositions for the treatment of viral infections. Idenix Pharmaceuticals, L Université Montpellier II, Jones Day, May 31, 2011: US07951789 (28 worldwide citation)

Provided herein are compounds, compositions and methods for the treatment of liver disorder, including HCV and/or HBV infections. Specifically, compound and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.


2
Jean Pierre Sommadossi, Gilles Gosselin, Claire Pierra, Christian Perigaud, Suzanne Peyrottes: Compounds and pharmaceutical compositions for the treatment of viral infections. Idenix Pharmaceuticals, L Université Montpellier II, Jones Day, March 8, 2011: US07902202 (16 worldwide citation)

Provided herein are compounds, compositions and methods for the treatment of liver disorder, including HCV and/or HBV infections. Specifically, compound and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.


3
Jean Pierre Sommadossi, Gilles Gosselin, Claire Pierra, Christian Perigaud, Suzanne Peyrottes: Compounds and pharmaceutical compositions for the treatment of viral infections. Idenix Pharmaceuticals, Centre National de la Recherche Scientifique, Universite Montpellier II, Jones Day, April 8, 2014: US08691788 (12 worldwide citation)

Provided herein are compounds, compositions and methods for the treatment of liver disorder, including HCV and/or HBV infections. Specifically, compound and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.


4

5
Gilles Gosselin, Jean Louis Imbach, Christian Perigaud: Biologically active phosphotriester-type nucleosides and methods for preparing same. Centre National de la Recherche Scientifique, Woodcock Washburn Kurtz Mackiewicz & Norris, December 15, 1998: US05849905 (7 worldwide citation)

Compounds of formula RS--P(.dbd.O) (QR)--Nu where: R is a radical --(CH.sub.2)n-W--X; X is a radical --C(.dbd.Z) (Y) or --S--U; Z is O or S; W is O or S; Q is O or S; Y and U are an alkyl, aryl or saccharide radical which is optionally substituted with, for example, an OH, SH or NH group; n is equal ...


6
Jean Pierre Sommadossi, Gilles Gosselin, Claire Pierra, Christian Perigaud, Suzanne Peyrottes: Compounds and pharmaceutical compositions for the treatment of viral infections. Idenix Pharmaceuticals, Jones Day, February 2, 2016: US09249173

Provided herein are compounds, compositions and methods for the treatment of liver disorder, including HCV and/or HBV infections. Specifically, compound and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.


7

8
Suzanne Peyrottes, Christian Perigaud, Céline Crauste: Method for preparing nucleotides and related analogues by synthesis on soluble substrate, and biological tools thus prepared. Centre National de la Recherche Scientifique, Universite Montpellier 2 Sciences et Techniques, John P White, Cooper & Dunham, December 24, 2013: US08614312

The invention concerns a method for preparing monomer nucleotides or nucleotide analogues comprising the steps of: (1) coupling a soluble polyethylene glycol support provided with at least one diacid or ether-acid linker and a monomer nucleoside or nucleoside analogue to an amine group or hydroxyl g ...


9
Jean Pierre Sommadossi, Gilles Gosselin, Claire Pierra, Christian Perigaud, Suzanne Peyrottes: Compounds and pharmaceutical compositions for the treatment of liver disorders. Idenix Pharmaceuticals, L Universite Montpellier Ii, Jones Day, October 23, 2008: US20080261913-A1

Provided herein are compounds, compositions and methods for the treatment of liver disorders, including liver cancer and metabolic diseases, such as diabetes, hyperlipidemia, atherosclerosis, and obesity. Specifically, compounds and compositions of nucleoside derivatives are disclosed, which can be ...


10
Jean Pierre Sommadossi, Gilles Gosselin, Claire Pierra, Christian Perigaud, Suzanne Peyrottes: Compounds and pharmaceutical compositions for the treatment of viral infections. Idenix Pharmaceuticals, L Universite Montpellier Ii, Jones Day, November 20, 2008: US20080286230-A1

Provided herein are compounds, compositions and methods for the treatment of liver disorder, including HCV and/or HBV infections. Specifically, compound and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.